tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IPHYF Stock Latest News

Innate Pharma’s NK Cell Engager Enters Phase 2 Trials
Company AnnouncementsInnate Pharma’s NK Cell Engager Enters Phase 2 Trials
16d ago
6K
Innate Pharma Announces Upcoming Annual General Meeting
PremiumCompany Announcements
Innate Pharma Announces Upcoming Annual General Meeting
16d ago
6K
Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
PremiumThe Fly
Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
17d ago
IPHA
Innate Pharma’s Growth at Risk: The Challenge of Relying on External Partners and a Lean Team
PremiumCompany Announcements
Innate Pharma’s Growth at Risk: The Challenge of Relying on External Partners and a Lean Team
27d ago
Innate Pharma S.A.: Financial Overview and Gains
PremiumCompany Announcements
Innate Pharma S.A.: Financial Overview and Gains
1M ago
6K
Innate Pharma S.A. Reports Strong 2023 Performance
PremiumCompany AnnouncementsInnate Pharma S.A. Reports Strong 2023 Performance
1M ago
6K
Innate Pharma Engages Investors at Virtual Conference
PremiumCompany Announcements
Innate Pharma Engages Investors at Virtual Conference
1M ago
6K
Innate Pharma announces first patient dosed in IPH6501 trial
PremiumThe Fly
Innate Pharma announces first patient dosed in IPH6501 trial
2M ago
IPHA
Innate Pharma announces Yannis Morel broadens remit to COO
PremiumThe Fly
Innate Pharma announces Yannis Morel broadens remit to COO
4M ago
IPHA
Innate Pharma announces FDA lifts clinical hold on lacutamab IND
PremiumThe Fly
Innate Pharma announces FDA lifts clinical hold on lacutamab IND
4M ago
IPHA
Sanofi exercises option to license NK cell engager program from Innate Pharma
PremiumThe Fly
Sanofi exercises option to license NK cell engager program from Innate Pharma
4M ago
SNY
IPHA
Innate Pharma CEO Mondher Mahjoubi resigns, Herve Brailly appointed interim CEO
PremiumThe Fly
Innate Pharma CEO Mondher Mahjoubi resigns, Herve Brailly appointed interim CEO
5M ago
IPHA
Innate announces updated efficacy, safety results from SAR443579 / IPH6101 study
PremiumThe FlyInnate announces updated efficacy, safety results from SAR443579 / IPH6101 study
5M ago
SNY
IPHA
Innate Pharma announces partial clinical hold on lacutamab IND placed by FDA
PremiumThe Fly
Innate Pharma announces partial clinical hold on lacutamab IND placed by FDA
7M ago
IPHA
Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results
PremiumThe Fly
Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results
7M ago
IPHA
Innate Pharma price target lowered to $8 from $12 at Citi
PremiumThe Fly
Innate Pharma price target lowered to $8 from $12 at Citi
8M ago
IPHA
Innate Pharma doses first patient in Sanofi-sponsored SAR’514 / IPH6401 trial
PremiumThe Fly
Innate Pharma doses first patient in Sanofi-sponsored SAR’514 / IPH6401 trial
10M ago
SNY
IPHA
Innate Pharma announces first patient dosed in MATISSE trial
PremiumThe Fly
Innate Pharma announces first patient dosed in MATISSE trial
10M ago
AZN
IPHA
Innate Pharma highlights increased lacutamab activity in TELLOMAK study
PremiumThe Fly
Innate Pharma highlights increased lacutamab activity in TELLOMAK study
11M ago
IPHA
Innate Pharma establishes at-the-market program on Nasdaq for up to $75M
PremiumThe FlyInnate Pharma establishes at-the-market program on Nasdaq for up to $75M
1y ago
IPHA
Innate Pharma price target raised to $10 from $9 at SVB Securities
PremiumThe Fly
Innate Pharma price target raised to $10 from $9 at SVB Securities
1y ago
TAK
IPHA
Innate Pharma announces $5M upfront payment from Takeda
PremiumThe Fly
Innate Pharma announces $5M upfront payment from Takeda
1y ago
TAK
IPHA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >